We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORBC
651
DELISTED
ORBCOMM, Inc.
ORBC
| $1.07M | 0.01% |
314,152
-335,020
| -52% | -$1.3M |
|
652
Puma Biotechnology
PBYI
$398M
| $1.05M | 0.01% |
104,543
-4,146
| -4% | -$42.2K |
|
653
iShares Russell 2000 Growth ETF
IWO
$14.1B
| $1.05M | 0.01% |
4,742
-509
| -10% | -$111K |
|
|
LEAF
654
DELISTED
Leaf Group Ltd.
LEAF
| $1.05M | 0.01% |
208,807
+179,793
| +620% | +$849K |
|
655
AnaptysBio
ANAB
$1.54B
| $1.04M | 0.01% |
70,851
+7,260
| +11% | +$131K |
|
|
FBC
656
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $1.04M | 0.01% |
35,193
+294
| +0.8% | +$8.85K |
|
657
InterDigital
IDCC
$6.75B
| $1.04M | 0.01% |
+18,222
| New | +$1.09M |
|
|
ODT
658
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.03M | 0.01% |
77,033
+23,129
| +43% | +$655K |
|
659
Community Trust Bancorp
CTBI
$1.42B
| $1.03M | 0.01% |
36,416
-4,543
| -11% | -$143K |
|
660
Bloomin' Brands
BLMN
$754M
| $1.02M | 0.01% |
67,100
-68,680
| -51% | -$889K |
|
|
HSII
661
DELISTED
Heidrick & Struggles
HSII
| $1.02M | 0.01% |
+52,063
| New | +$1.09M |
|
662
Metropolitan Bank Holding Corp
MCB
$1.15B
| $1.02M | 0.01% |
36,478
-4,083
| -10% | -$122K |
|
|
HZNP
663
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.02M | 0.01% |
+13,117
| New | +$903K |
|
664
Gen Digital
GEN
$16.5B
| $1.02M | 0.01% |
48,787
+9,245
| +23% | +$200K |
|
|
SNR
665
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $1.01M | 0.01% |
253,411
+100,940
| +66% | +$397K |
|
|
ADVM
666
DELISTED
Adverum Biotechnologies
ADVM
| $994K | 0.01% |
9,654
-1,015
| -10% | -$152K |
|
667
Titan International
TWI
$492M
| $991K | 0.01% |
342,908
+279,168
| +438% | +$615K |
|
|
BLD
668
DELISTED
TopBuild
BLD
| $986K | 0.01% |
5,777
-5,364
| -48% | -$770K |
|
669
Alnylam Pharmaceuticals
ALNY
$38.3B
| $983K | 0.01% |
+6,753
| New | +$960K |
|
670
Amalgamated Financial
AMAL
$1.47B
| $981K | 0.01% |
92,707
-8,672
| -9% | -$101K |
|
671
Peapack-Gladstone Financial
PGC
$815M
| $981K | 0.01% |
64,762
-9,159
| -12% | -$154K |
|
|
NPKI
672
NPK International
NPKI
$1.02B
| $981K | 0.01% |
933,939
+485,608
| +108% | +$892K |
|
673
Ultragenyx Pharmaceutical
RARE
$2.46B
| $978K | 0.01% |
11,898
-14,908
| -56% | -$1.24M |
|
|
K
674
DELISTED
Kellanova
K
| $957K | 0.01% |
15,780
+2,706
| +21% | +$172K |
|
675
Duke Energy
DUK
$101B
| $954K | 0.01% |
10,776
-9,785
| -48% | -$807K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.